生活方式与牙周炎的关联及系统性炎症的中介作用研究

注册号:

Registration number:

ChiCTR2500104002 

最近更新日期:

Date of Last Refreshed on:

2025-06-10 08:53:09 

注册时间:

Date of Registration:

2025-06-10 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

生活方式与牙周炎的关联及系统性炎症的中介作用研究

Public title:

The association between healthy lifestyle and periodontitis and the mediating effect of inflammation

注册题目简写:

English Acronym:

研究课题的正式科学名称:

生活方式与牙周炎的关联及系统性炎症的中介作用研究

Scientific title:

The association between healthy lifestyle and periodontitis and the mediating effect of inflammation

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

包晗 

研究负责人:

吴贇 

Applicant:

Han Bao 

Study leader:

Yun Wu 

申请注册联系人电话:

Applicant telephone:

+86 166 0399 6261

研究负责人电话:

Study leader's
telephone:

+86 150 0599 0520

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

931119740@qq.com

研究负责人电子邮件:

Study leader's E-mail:

1574316628@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

福建省福州市台江区茶中路20号福建医科大学附属第一医院

研究负责人通讯地址:

福建省福州市台江区茶中路20号福建医科大学附属第一医院

Applicant address:

The First Affiliated Hospital of Fujian Medical University, No. 20, Cha-Zhong Road, Taijiang District, Fuzhou City, Fujian Province

Study leader's address:

The First Affiliated Hospital of Fujian Medical University, No. 20, Cha-Zhong Road, Taijiang District, Fuzhou City, Fujian Province

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

福建医科大学

Applicant's institution:

Fujian Medical University

研究负责人所在单位:

福建医科大学附属第一医院

Affiliation of the Leader:

The First Affiliated Hospital of Fujian Medical University

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

闽医大附一伦理医研[2025]646号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

福建医科大学附属第一医院医学伦理委员会医学研究与临床技术应用分会

Name of the ethic committee:

Medical Research and Clinical Technology Application Branch, Medical Ethics Committee, the First Affiliated Hospital of Fujian Medical University

伦理委员会批准日期:

Date of approved by ethic committee:

2025-06-04 00:00:00

伦理委员会联系人:

翁山耕

Contact Name of the ethic committee:

Shangeng Weng

伦理委员会联系地址:

福建省福州市台江区茶中路20号

Contact Address of the ethic committee:

20 Cha-Zhong Road, Taijiang District, Fuzhou City, Fujian Province

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 591 8798 1029

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

福建医科大学附属第一医院

Primary sponsor:

The First Affiliated Hospital of Fujian Medical University

研究实施负责(组长)单位地址:

福建省福州市台江区茶中路20号

Primary sponsor's address:

20 Cha-Zhong Road, Taijiang District, Fuzhou City, Fujian Province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

福建

市(区县):

福州

Country:

China

Province:

Fujian

City:

Fuzhou

单位(医院):

福建医科大学附属第一医院

具体地址:

福建省福州市台江区茶中路20号

Institution
hospital:

The First Affiliated Hospital of Fujian Medical University

Address:

20 Cha-Zhong Road, Taijiang District, Fuzhou City, Fujian Province

经费或物资来源:

福建医科大学附属第一医院

Source(s) of funding:

The First Affiliated Hospital of Fujian Medical University

研究疾病:

牙周炎  

Target disease:

Periodontitis

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

横断面 

Study design:

Cross-sectional 

研究目的:

①探究不同生活方式与牙周炎严重程度之间的关联 ②探究系统性炎症指数与牙周炎严重程度之间的关联 ③探讨系统性炎症在生活方式影响牙周炎严重程度中的中介效应  

Objectives of Study:

1 To explore the relationship between different lifestyle and the severity of periodontitis 2 To explore the association between systemic inflammation index and periodontitis severity 3 To investigate the mediating effect of systemic inflammation on the severity of periodontitis in lifestyle

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

①因全身健康因素或其他因素,不能接受口腔牙周健康状况检查者;②患有血液系统相关疾病;③基线患有急性炎症或感染性疾病者;④当前位于妊娠或哺乳期;⑤患有恶性肿瘤者;⑥就诊前3月内曾连续大剂量使用抗生素、非甾体类抗炎药、激素、免疫相关药物;就诊前短期服用抗生素后,停药未超过1周的患者;

Exclusion criteria:

1 Because of general health factors or other factors, can not accept the oral periodontal health status examination; 2 Suffering from blood system related diseases; 3 Patients with acute inflammatory or infectious diseases at baseline; 4 Currently in the pregnancy or lactation period; 5 Patients with malignant tumors; 6 Continuous use of antibiotics, non-steroidal anti-inflammatory drugs, hormones, and immune-related drugs within 3 months before treatment; Patients who stopped taking antibiotics for less than 1 week after taking them for a short period before visiting the doctor;

研究实施时间:

Study execute time:

From 2025-06-04 00:00:00 To 2026-06-30 00:00:00  

征募观察对象时间:

Recruiting time:

From 2025-06-10 00:00:00 To 2026-06-30 00:00:00

干预措施:

Interventions:

组别:

病例组

样本量:

500

Group:

Case series

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

福建 

市(区县):

福州 

Country:

China

Province:

Fujian

City:

Fuzhou

单位(医院):

福建医科大学附属第一医院 

单位级别:

三甲 

Institution
hospital:

The First Affiliated Hospital of Fujian Medical University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

探诊深度

指标类型:

主要指标

Outcome:

Probing Depth,PD

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

临床附着丧失

指标类型:

主要指标

Outcome:

Clinical Attachment Loss,CAL

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

菌斑指数

指标类型:

次要指标

Outcome:

Plaque Index,PLI

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

探诊出血

指标类型:

次要指标

Outcome:

Bleeding on Probing,BOP

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

松动度

指标类型:

次要指标

Outcome:

Tooth Mobility,TM

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

全口出血指数

指标类型:

次要指标

Outcome:

Full Mouth Bleeding Scores,FMBS

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

全口菌斑指数

指标类型:

次要指标

Outcome:

Full Mouth Plaque Scores,FMPS

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

根分叉病变

指标类型:

次要指标

Outcome:

Furcation Involvement,FI

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

国际体力活动量表

指标类型:

主要指标

Outcome:

International Physical Activity Questionnaire,IPAQ

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

地中海饮食遵从性量表

指标类型:

主要指标

Outcome:

Adherence to Mediterranean Diet,QueMD

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

匹兹堡睡眠质量指数量表

指标类型:

主要指标

Outcome:

Pittsburgh Sleep Quality Index,PSQI

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

压力知觉量表

指标类型:

主要指标

Outcome:

Perceived Stress Scale-10,PSS-10

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

系统免疫炎症指数(SII)

指标类型:

主要指标

Outcome:

Systemic immune inflammation index

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

系统性炎症反应指数(SIRI)

指标类型:

主要指标

Outcome:

Systemic Inflammatory Response Index

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 70 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

None

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

2026年以论文或调查报告的方式公开

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Publicly available in the form of papers or survey reports in 2026

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

电子采集与管理系统

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Electronic Data Capture, EDC

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2025-06-10 08:53:04